ePharmaSolutions to acquire global patient recruitment firm Polaris BioPharma

Wednesday, June 20, 2012 03:06 PM

ePharmaSolutions, a clinical services and technology solutions provider, has acquired Polaris BioPharma Consulting, a global patient recruitment and retention firm based in Slough, U.K., to meet client demand for more "in-country" site feasibility and patient recruitment support on global clinical studies.

The acquisition increases PharmaSolutions' global bandwidth while expanding its core workforce with a team of experienced patient recruitment specialists in every major continent who can implement global projects at the local level.

"We have worked closely with Polaris over the last 10 years on some very complex projects, and they have always delivered," said Lance Converse, founder and CEO of ePharmaSolutions. "They have a wealth of knowledge of the regulatory, clinical and cultural landscape, from a local perspective, and have connections with varied regional referral sources to expedite study enrollment. This addition is integral to the company's continued growth."

Polaris Biopharma was founded in 1999 as a boutique patient recruitment and retention firm supporting global pharmaceutical companies.  Over the last 13 years, Polaris has grown to 20 local recruitment specialists in every continent providing in-country support on global recruitment campaigns.

"We are proud to be a part of ePharmaSolutions and committed to our collective mission to improve and accelerate clinical trials through empirical expertise in patient recruitment, compliance and retention," said Sanjiv Kanwar, managing director of Polaris Biopharma's. "We can now fully leverage the data-driven technology assets ePharmaSolutions has developed with Polaris' global experience and regionally based recruitment specialists to provide sponsors with high-impact, results-driven site feasibility and patient recruitment campaigns."

ePharmaSolutions and Polaris will be attending the Annual DIA Meeting in Philadelphia June 25-28 at booth 1427.

Share:          
CWWeekly

March 2

Huntingdon Life Sciences-Harlan prepares for rebranding and U.S. expansion to compete with early phase CROs Covance, CRL

Patients' increased sharing of clinical trial experiences through social media can help sponsors improve outcomes, enrollment

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs